skinhealth systems inc - SKIN

SKIN

Close Chg Chg %
0.69 0.00 0.00%

Closed Market

0.69

0.00 (0.00%)

Volume: 275.52K

Last Updated:

Sep 10, 2026, 4:00 PM EDT

Company Overview: skinhealth systems inc - SKIN

SKIN Key Data

Open

$0.69

Day Range

0.67 - 0.69

52 Week Range

0.55 - 2.69

Market Cap

$96.30M

Shares Outstanding

130.14M

Public Float

79.69M

Beta

1.00

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.22

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

378.84K

 

SKIN Performance

1 Week
 
0.73%
 
1 Month
 
2.30%
 
3 Months
 
5.54%
 
1 Year
 
-72.73%
 
5 Years
 
-97.36%
 

SKIN Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 9
Full Ratings ➔

About skinhealth systems inc - SKIN

Skinhealth Systems, Inc. engages in the design, development, manufacture, marketing, and sale of esthetic technologies and products. Its brands include Hydrafacial, SkinStylus, and Keravive. The company was founded in 1997 and is headquartered in Long Beach, CA.

SKIN At a Glance

Skinhealth Systems, Inc.
2165 Spring Street
Long Beach, California 90806
Phone 1-800-603-4996 Revenue 300.79M
Industry Medical Specialties Net Income -9,519,000.00
Sector Health Technology Employees 613
Fiscal Year-end 12 / 2026
View SEC Filings

SKIN Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.628
Price to Book Ratio 2.903
Price to Cash Flow Ratio 5.04
Enterprise Value to EBITDA 10,146.742
Enterprise Value to Sales 1.113
Total Debt to Enterprise Value 1.131

SKIN Efficiency

Revenue/Employee 490,685.155
Income Per Employee -15,528.548
Receivables Turnover 12.834
Total Asset Turnover 0.507

SKIN Liquidity

Current Ratio 1.662
Quick Ratio 1.404
Cash Ratio 1.249

SKIN Profitability

Gross Margin 65.283
Operating Margin -6.916
Pretax Margin -1.974
Net Margin -3.165
Return on Assets -1.606
Return on Equity -16.869
Return on Total Capital -2.164
Return on Invested Capital -2.057

SKIN Capital Structure

Total Debt to Total Equity 620.342
Total Debt to Total Capital 86.118
Total Debt to Total Assets 75.781
Long-Term Debt to Equity 408.918
Long-Term Debt to Total Capital 56.767
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Skinhealth Systems Inc - SKIN

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
365.88M 397.99M 334.29M 300.79M
Sales Growth
+40.68% +8.78% -16.00% -10.02%
Cost of Goods Sold (COGS) incl D&A
121.53M 242.88M 144.00M 104.43M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
26.58M 32.24M 29.48M 20.84M
Depreciation
11.72M 11.33M 9.94M 3.85M
Amortization of Intangibles
14.85M 20.91M 19.54M 16.99M
COGS Growth
+41.76% +99.85% -40.71% -27.48%
Gross Income
244.35M 155.11M 190.30M 196.36M
Gross Income Growth
+40.14% -36.52% +22.68% +3.19%
Gross Profit Margin
+66.78% +38.97% +56.92% +65.28%
2022 2023 2024 2025 5-year trend
SG&A Expense
247.40M 278.83M 250.07M 217.17M
Research & Development
8.44M 10.10M 6.30M 5.63M
Other SG&A
238.96M 268.73M 243.77M 211.54M
SGA Growth
+43.78% +12.70% -10.31% -13.16%
Other Operating Expense
- - - -
-
Unusual Expense
(56.96M) (4.72M) 4.93M (487.00K)
EBIT after Unusual Expense
53.91M (119.00M) (64.71M) (20.32M)
Non Operating Income/Expense
4.52M 30.76M 45.57M 33.70M
Non-Operating Interest Income
9.18M 23.17M 16.64M 8.95M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
13.39M 13.65M 10.41M 19.33M
Interest Expense Growth
+13.71% +1.92% -23.72% +85.61%
Gross Interest Expense
13.39M 13.65M 10.41M 19.33M
Interest Capitalized
- - - -
-
Pretax Income
45.03M (101.89M) (29.55M) (5.94M)
Pretax Income Growth
+111.93% -326.26% +71.00% +79.91%
Pretax Margin
+12.31% -25.60% -8.84% -1.97%
Income Tax
648.00K (1.77M) (452.00K) 3.58M
Income Tax - Current - Domestic
713.00K 250.00K 142.00K 370.00K
Income Tax - Current - Foreign
1.72M 3.79M 3.00M 1.33M
Income Tax - Deferred - Domestic
- - (423.00K) (4.77M)
-
Income Tax - Deferred - Foreign
(1.36M) (1.05M) (3.60M) 1.88M
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
44.38M (100.12M) (29.10M) (9.52M)
Minority Interest Expense
- - - -
-
Net Income
44.38M (100.12M) (29.10M) (9.52M)
Net Income Growth
+111.83% -325.57% +70.94% +67.29%
Net Margin Growth
+12.13% -25.16% -8.70% -3.16%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
44.38M (100.12M) (29.10M) (9.52M)
Preferred Dividends
- - - -
-
Net Income Available to Common
44.38M (100.12M) (29.10M) (9.52M)
EPS (Basic)
0.3008 -0.7603 -0.235 -0.0753
EPS (Basic) Growth
+108.19% -352.76% +69.09% +67.96%
Basic Shares Outstanding
147.55M 131.68M 123.83M 126.38M
EPS (Diluted)
-0.2287 -0.7603 -0.3633 -0.1628
EPS (Diluted) Growth
+93.77% -232.44% +52.22% +55.19%
Diluted Shares Outstanding
148.51M 131.68M 142.49M 135.80M
EBITDA
23.52M (91.48M) (30.30M) 33.00K
EBITDA Growth
+0.41% -488.90% +66.88% +100.11%
EBITDA Margin
+6.43% -22.98% -9.06% +0.01%

Snapshot

Average Recommendation HOLD Average Target Price 1.042
Number of Ratings 9 Current Quarters Estimate -0.064
FY Report Date 09 / 2026 Current Year's Estimate -0.16
Last Quarter’s Earnings -0.02 Median PE on CY Estimate N/A
Year Ago Earnings -0.08 Next Fiscal Year Estimate -0.039
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 8 8 8 9
Mean Estimate -0.06 -0.02 -0.16 -0.04
High Estimates -0.04 0.00 -0.12 0.05
Low Estimate -0.09 -0.05 -0.20 -0.15
Coefficient of Variance -27.73 -104.70 -19.76 -204.28

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 1 1
OVERWEIGHT 0 0 0
HOLD 6 6 6
UNDERWEIGHT 0 0 0
SELL 2 2 2
MEAN Hold Hold Hold

Skinhealth Systems Inc in the News